BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31126066)

  • 1. Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer.
    Yeh SJ; Lin CY; Li CW; Chen BS
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
    Tang X; Huang X; Wang D; Yan R; Lu F; Cheng C; Li Y; Xu J
    Gene; 2019 Jul; 704():142-148. PubMed ID: 30965127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
    Zhao H; Li H
    Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method.
    Li CW; Chang PY; Chen BS
    Oncotarget; 2016 Nov; 7(48):79453-79473. PubMed ID: 27821810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
    Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis.
    Liu Y; Chen TY; Yang ZY; Fang W; Wu Q; Zhang C
    J Transl Med; 2020 Apr; 18(1):170. PubMed ID: 32299435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating Pathogenetic Mechanisms of Alzheimer's Disease by Systems Biology Approaches for Drug Discovery.
    Yeh SJ; Chung MH; Chen BS
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network medicine approaches for identification of novel prognostic systems biomarkers and drug candidates for papillary thyroid carcinoma.
    Kori M; Temiz K; Gov E
    J Cell Mol Med; 2023 Dec; 27(24):4171-4180. PubMed ID: 37859510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Network-Based Identification of Circular RNA-Associated ceRNA Network in Papillary Thyroid Cancer.
    Liu Q; Pan LZ; Hu M; Ma JY
    Pathol Oncol Res; 2020 Apr; 26(2):1293-1299. PubMed ID: 31289996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma.
    Zhang S; Wang Y; Chen M; Sun L; Han J; Elena VK; Qiao H
    Sci Rep; 2017 Mar; 7():44033. PubMed ID: 28272462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer.
    Bansal R; Saxena U
    Appl Biochem Biotechnol; 2023 May; 195(5):2917-2932. PubMed ID: 36445679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating Pathogenic and Hepatocarcinogenic Mechanisms from Normal Liver to HCC by Constructing Genetic and Epigenetic Networks via Big Genetic and Epigenetic Data Mining and Genome-Wide NGS Data Identification.
    Li CW; Chiu YK; Chen BS
    Dis Markers; 2018; 2018():8635329. PubMed ID: 30344796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of a set of microRNA genes reveals the potential mechanism of papillary thyroid carcinoma.
    Feng Z; Song Y; Qian J; Chen T; Yang C; Jia L; Liu C; Liu P; Lv J; Deng Z
    Ann Endocrinol (Paris); 2019 Apr; 80(2):77-83. PubMed ID: 30685058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.
    Zhai T; Muhanhali D; Jia X; Wu Z; Cai Z; Ling Y
    Endocrine; 2019 Dec; 66(3):573-584. PubMed ID: 31332712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentiated functional modules in papillary thyroid carcinoma by analyzing differential networks.
    Yang C; Wang Y
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S969-S974. PubMed ID: 30539831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analysis of genes associated with papillary thyroid carcinoma by bioinformatics methods.
    Zhang S; Wang Q; Han Q; Han H; Lu P
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30872410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
    Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer.
    Yeh SJ; Chen SW; Chen BS
    Front Genet; 2020; 11():117. PubMed ID: 32211020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma.
    Reyes I; Reyes N; Suriano R; Iacob C; Suslina N; Policastro A; Moscatello A; Schantz S; Tiwari RK; Geliebter J
    Cancer Biomark; 2019; 24(1):71-83. PubMed ID: 30614796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma.
    Han J; Chen M; Wang Y; Gong B; Zhuang T; Liang L; Qiao H
    Sci Rep; 2018 Jul; 8(1):9912. PubMed ID: 29967488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.